TITLE

Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income Countries

AUTHOR(S)
Lawn, Stephen D.; Wood, Robin
PUB. DATE
December 2005
SOURCE
Clinical Infectious Diseases;12/15/2005, Vol. 41 Issue 12, p1783
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article presents the author's comments on the incidence of Tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. Highly active antiretroviral therapy (HAART) has revolutionized the care of HIV-infected individuals, causing major reductions in HIV-associated morbidity and mortality. In contrast, however, it is emerging that patients receiving HAART retain a chronically heightened risk of disease due to other, more virulent pathogens, such as tuberculosis (TB) and invasive pneumococcal disease. In conclusion, despite major reductions in TB incidence among individuals receiving HAART, TB risk remains elevated among those receiving treatment in both high- and low-income countries.
ACCESSION #
19074496

 

Related Articles

  • Mortality Among Patients with Tuberculosis and Associations with HIV Status -- United States, 1993-2008. Shah, S.; Cain, K.; Marks, S.; Cavanaugh, J. // MMWR: Morbidity & Mortality Weekly Report;11/26/2010, Vol. 59 Issue 46, p1509 

    The article discusses a study on the impact of the HIV on the risk of death on patients with tuberculosis (TB) during treatment in the U.S. from 1993 to 2008. Studies showed that HIV patients are more at risk of acquiring TB and in turn have a higher mortality risk where there is limited access...

  • Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era. Gopal, Satish; Patel, Monita R.; Yanik, Elizabeth L.; Cole, Stephen R.; Achenbach, Chad J.; Napravnik, Sonia; Burkholder, Greer A.; Reid, Erin G.; Rodriguez, Benigno; Deeks, Steven G.; Mayer, Kenneth H.; Moore, Richard D.; Kitahata, Mari M.; Eron, Joseph J.; Richards, Kristy L. // JNCI: Journal of the National Cancer Institute;8/21/2013, Vol. 105 Issue 16, p1221 

    Background Lymphoma is the leading cause of cancer-related death among HIV-infected patients in the antiretroviral therapy (ART) era. Methods We studied lymphoma patients in the Centers for AIDS Research Network of Integrated Clinical Systems from 1996 until 2010. We examined differences...

  • Pharmacokinetic interactions between antiretrovirals and rifampicin-based tuberculosis treatment. Cohen, Karen // CME: Continuing Medical Education;Oct2011, Vol. 29 Issue 10, p429 

    The article explains the role of pharmacokinetic interactions in antiretroviral treatment (ART) for patients co-infected with HIV and tuberculosis (TB) in South Africa. The pharmacokinetic interaction are being tapped as potential treatment alternatives to Rifampicin, a drug that is applied on...

  • HIV-Tuberculosis Co-infection in Southern India-a record based study. Pattanshetty, Sanjay M.; Kumar, A.; Pandit, V.; Sneha, K.; Darshan, B. B. // Australasian Medical Journal;Oct2010, Vol. 3 Issue 10, p690 

    The article discusses the study conducted at an Anti-retroviral therapy (ART) centre of Udupi district, South India, which analyzes the tuberculosis (TB)-HIV con-infection among patients on ART. It states that combined pulmonary and extrapulmonary form of TB were common in HIV seropositive...

  • Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.  // AIDS Research & Therapy;2012, Vol. 9, p15 

    The article offers information regarding a study which aimed to examine mortality and its predictors among a cohort of HIV infected patients on anti-retroviral treatment retrospectively followed for five years in Ethiopia. As reported, a total of 1540 study participants were included. As stated,...

  • Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Brinkhof, Martin W.G.; Dabis, François; Myer, Landon; Bangsberg, David R.; Boulle, Andrew; Nash, Denis; Schechter, Mauro; Laurent, Christian; Keiser, Olivia; May, Margaret; Sprinz, Eduardo; Egger, Matthias; Anglaret 2, Xavier // Bulletin of the World Health Organization;Jul2008, Vol. 86 Issue 7, p559 

    Objective To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resource-limited settings. Methods Using data on 5491 adult patients starting ART (median age 35 years, 46% female) in 15 treatment programmes in Africa, Asia and South America with ≥ 12 months of...

  • Early HIV treatment dramatically increases survival in patients co-infected with tuberculosis.  // Biomedical Market Newsletter;10/26/2011, Vol. 21, p748 

    The article presents a research study which focuses on the effectiveness of antiretrovirals (ART) and anti-tuberculosis medications in extending the survivability of patients who are suffering from HIV and tuberculosis. Researcher and physician Anne Goldfeld has suggested the World Health...

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

  • Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series. Báez-Saldaña, Renata; Villafuerte-García, Adriana; Cruz-Hervert, Pablo; Delgado-Sánchez, Guadalupe; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Mongua-Rodríguez, Norma; Montero-Campos, Rogelio; Melchor-Romero, Ada; García-García, Lourdes // PLoS ONE;9/17/2015, Vol. 10 Issue 9, p1 

    Background: Respiratory manifestations of HIV disease differ globally due to differences in current availability of effective highly active antiretroviral therapy (HAART) programs and epidemiology of infectious diseases. Objective: To describe the association between HAART and discharge...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics